Informed decision making: Age of 50 is arbitrary and has no demonstrated influence on breast cancer screening in women

American Journal of Roentgenology

Volumn 185, Issue 1, 2005, Pages 177-182

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; CLINICAL TRIAL; DECISION MAKING; HEALTH CARE; HUMAN; MAMMOGRAPHY; MENOPAUSE; PARAMETER; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; ADULT; AGE; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; FEMALE; MASS SCREENING; MIDDLE AGED; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE FACTORS; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MENOPAUSE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS;

EID: 24644432076     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Marchione M. MRI finds more breast tumors in study. The Boston Globe, July 29,2004:2
2. Sickles EA, Kopans DB. Deficiencies in the analysis of the breast cancer screening data. J Natl Cancer Inst 1993; 85:1621-1624
3. Sickles EA, Kopans DB. Mammographic screening for women aged 40 to 49 years: the primary care practitioner's dilemma. Am Intern Med 1995; 122:534-538
4. Hetcher SW, Black W, Harris R, et al. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993; 85:1644-1656
5. Harris R, Leininger L. Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 1995; 122:539-547
6. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 348; 17:1672-1680
7. Thornton H, Edwards A, Baum M, et al. Women need better information about routine mammography. BMJ 2003; 327:101-103
8. Baines CJ. Mammography screening: are women really giving informed consent? J Natl Cancer Inst 2003; 95:1508-1511
9. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275:913-918
10. Harris RP, Fletcher SW, Gonzalez JJ, et al. Mammography and age: are we targeting the wrong women? Cancer 1991; 67:2010-2014
11. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40-49. Can Med Assoc J 1992; 147:1459-1476
12. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials 1993; doc. no. 32
13. [Erratum in: Online J Curr Clin Trials 1993; doc. no. 34]
14. Fletcher SW, Hetcher RH. The breast is close to the heart. Ann Intern Med 1992; 117:969-971
15. Van Dijck JAAM, Verbeek ALM, Hendriks JHCL, Holland R. The current detectability of breast cancer in a mammographic screening program. Cancer 1993; 72:1933-1938
16. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993; 270:2444-2450
17. Randall T. Varied mammogram readings worry researchers. JAMA 1993; 269:2616-2617
18. Chalmers TC. Screening for breast cancer: what should national health policy be? J Natl Cancer Inst 1993; 85:1619-1621
19. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995; 273:149-153
20. Lee Davis D, Love SM. Mammographic screening. JAMA 1994; 271:152-153
21. Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994; 120:326-334
22. Peer PG, Holland R, Hendriks JH, Mravunac M, Verbeek ALM. Age-specific effectiveness of Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness. J Natl Cancer Inst 1994; 86:436-441
23. Kattiove H, Alessandro L, Keeler E, Brook RH. Benefits and costs of screening for early breast cancer: development of a basic benefit package. JAMA 1995; 273:142-148
24. Sox H. Screening mammography in women younger than 50 years of age. Ann Intern Med 1995; 122:550-552
25. Harris R. Breast cancer among women in their forties: toward a reasonable research agenda. J Natl Cancer Inst 1994; 86:410-412
26. Kaluzny AD, Rimer B, Harris R. The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy. J NatlCancer Inst 1994; 86:901-903
27. Swanson GM. May we agree to disagree, or how do we develop guidelines for breast cancer screening in women? J Natl Cancer Inst 1994; 86:903-905
28. Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995; 87:720-731
29. Rimer B. Putting the "informed" in informed consent about mammography. J Natl Cancer Inst 1995; 87:703-704
30. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 1995; 87:1217-1223
31. www.cancerscreening.nhs.uk/breastscreen/index.html#under50. Accessed May 2, 2005
32. www.seer.omcer.gov/cgi-bin/csr/search.pL#results. Accessed July 17, 2004
33. Tabar L, Yen MF, Vitak B, Tony Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 361:1405-1410
34. Kopans DB. The breast cancer screening controversy: lessons to be learned. J Surg Oncol 1998; 67:143-150
35. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR 1993; 161:755-760
36. Hoey J. Mammography screening among women aged 40-49 years shows no benefit. CMAJ 2002; 167:898
37. Miller AB, Howe GR, Wall C. The national study of breast cancer screening. Clin Invest Med 1981; 4:227-258
38. Bailar JC, MacMahon B. Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. Can Med Assoc J 1997; 156:193-199
39. Kopans DB, NBSS: opportunity to compromise the process, [letter to the editor] Can Med Assoc J 1997; 157:247
40. Tarone RE. The excess of patients with advanced breast cancers in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995; 75:997-1003
41. Baines CJ, Miller AB, Kopans DB, et al. Canadian National Breast Screening Study: assessment of technical quality by external review. AJR 1990; 155:743-747
42. Kopans DB. The Canadian screening program: a different perspective. AJR 1990; 155:748-749
43. Yaffe MJ. Correction: Canada study, [letter to the editor] JNCI 1993; 85:94
44. Shapiro S. Screening: assessment of current studies. Cancer 1994; 74:231-238
45. Duffy SW, Tabar L, Smith RA. The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA Cancer J Clin 2002; 52:68-71
46. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 1981; 2:93-113
47. Moher D, Dulberg C, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272:122-124
48. Kopans, DB. The National Breast Screening Study of Canada. A critical review of the results for women ages 40-49. Presented to the International Workshop on Screening of Breast Cancer. Bethesda, MD: February 24-25,1993
49. Kopans DB, Halpern E, Hulka CA. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 with particular emphasis on the National Breast Screening Study of Canada. Cancer 1994; 74:1196-1203
50. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women ages 40-49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997; 22:87-92
51. Bjurstam N, Bjorneld L, Duffy S, et al. The Gothenberg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women ages 39-49. Monogr Natl Cancer Inst 1997; 22:53-55
52. Andersson I, Janzon L. Reduced breast cancer mortality in women under 50: update from the Malmö mammographic screening program. Monogr Natl Cancer Inst 1997; 22:63-67
53. Kopans DB, Monsees B, Feig SA. Screening for cancer: when is it valid? Lessons from the mammography experience. Radiology 2003;229:319-327
54. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR 1996; 167:1261-1265
55. Sox HC. Current controversies in screening: cholesterol, breast cancer, and prostate cancer. Mt Sinai J Med 1999; 66:91-101
56. Kopans DB. Conventional wisdom: observation, experience, anecdote, and science in breast imaging. AJR 1994; 162:299-303
57. Sox HC. Benefit and harm associated with screening for breast cancer. N Engl J Med 1998; 338:1145-1146
58. Kopans DB, Moore RH, McCarthy KA, et al. Biasing the interpretation of mammography screening data by age grouping: nothing changes abruptly at age 50. The Breast Journal 1998; 4:139-145